Seer (SEER) IPO Opens 153% Higher

Today's IPO for Seer, Inc. (NASDAQ: SEER) opened for trading at $48 after pricing its initial public offering of 9,210,527 shares of Class A common stock at a public offering price of $19.00 per share.

In addition, Seer has granted the underwriters a 30-day option to purchase up to an additional 1,381,579 shares of Class A common stock at the initial public offering price, less the underwriting discounts and commissions.

J.P. Morgan, Morgan Stanley, BofA Securities and Cowen are acting as lead book-running managers for the offering.

Seer is a life sciences company focused on enabling exceptional scientific outcomes by commercializing transformative products that will drive breakthrough ideas by unlocking the deep, unbiased biological information that can make them a reality. Seer is developing its Proteograph™, which is an integrated solution consisting of consumables, automation instrumentation and proprietary software that performs deep, unbiased proteomics analysis at scale in a matter of hours. Seer designed the Proteograph to be efficient and easy-to-use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution broadly available to life sciences researchers.

You May Also Be Interested In

• IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
• Analysts favorite fintech stock Adyen tumbles after revenue miss
• Tungray Technologies (TRSG) Closes $5M IPO